Intravenous Iron Dosing for Iron Deficiency Anemia
For adults with iron deficiency anemia requiring intravenous iron, administer a total cumulative dose of 1000-1500 mg of elemental iron, with the higher dose (1500 mg) being more effective at achieving complete iron repletion and reducing retreatment requirements. 1
Oral Iron Therapy (First-Line)
Start with oral iron at 50-100 mg elemental iron once daily taken on an empty stomach (e.g., one ferrous sulfate 200 mg tablet containing 65 mg elemental iron). 2, 3
- Continue oral iron for 2-3 months after hemoglobin normalization to replenish iron stores 2, 3
- Check hemoglobin at 2 weeks: absence of at least 10 g/L rise predicts treatment failure with 90% sensitivity 2, 3
- Recheck hemoglobin every 4 weeks until normalized 2, 3
When to Switch to Intravenous Iron
Reserve IV iron for patients with:
- Severe intolerance to oral iron (GI disturbance) 2, 3
- Malabsorption (celiac disease, post-bariatric surgery, inflammatory bowel disease) 2, 3
- Ongoing blood loss that exceeds oral replacement capacity 2, 3
- Chronic inflammatory conditions (active IBD, chronic kidney disease) 2, 3
- Failure to respond to oral iron after 2 weeks 2, 3
Intravenous Iron Dosing Regimens
Total Dose Calculation
The average iron deficit in IDA patients is approximately 1400-1500 mg of elemental iron. 1 A cumulative dose of 1500 mg results in significantly lower retreatment rates (5.6%) compared to 1000 mg (11.1%, p<0.001). 1
Formulation-Specific Dosing
High-dose formulations (single or two-dose regimens):
Ferric carboxymaltose: Maximum 1000 mg per infusion or 20 mg/kg (whichever is lower), infused over 15 minutes 2
Ferric derisomaltose: Maximum 20 mg/kg per infusion, infused over 15-30 minutes 2
- Can give total dose replacement in 1-2 infusions 2
Low molecular weight iron dextran: Maximum 20 mg/kg per infusion, infused over 4-6 hours 2
Low-dose formulations (multiple-dose regimens):
Iron sucrose: Maximum 200 mg per infusion, infused over 30 minutes 2
Ferric gluconate: 125 mg per dialysis session (or 62.5 mg in primary care), infused over 1 hour 5, 6
Practical Dosing Algorithm for Hemodialysis Patients
For chronic kidney disease patients on hemodialysis:
- Give 100-125 mg IV iron at every dialysis session for 8-10 doses (total 800-1250 mg) 2
- Once TSAT ≥20% and ferritin ≥100 ng/mL, maintain with 25-125 mg IV weekly 2
- Monitor TSAT and ferritin every 3 months 2
- Withhold IV iron if TSAT >50% or ferritin >800 ng/mL for up to 3 months 2
Critical Monitoring Parameters
Safety thresholds to prevent iron overload:
- Temporarily withhold IV iron if TSAT >50% or ferritin >800 ng/mL 2
- Resume at reduced dose (one-third to one-half previous dose) when levels normalize 2
Response monitoring:
- IV iron produces clinically meaningful hemoglobin response within 1 week 2, 3
- Check hemoglobin every 4 weeks until normalized 2, 3
- Once normalized, monitor every 3 months for 12 months, then every 6 months for 2-3 years 2
Common Pitfalls to Avoid
Underdosing: The most common error is giving only 1000 mg total when the actual deficit is 1400-1500 mg, leading to incomplete repletion and need for retreatment. 1
Test dose confusion: Only iron dextran formulations require a test dose of 25 mg. 2 Modern formulations (ferric carboxymaltose, ferric derisomaltose, iron sucrose) do not require test doses. 2
Hypophosphatemia risk: Ferric carboxymaltose causes hypophosphatemia in 58% of patients (vs 4% with ferric derisomaltose, 1% with iron sucrose), though most cases are asymptomatic and self-limited. 2
Blood transfusion overuse: Transfusion should be reserved only for severe symptomatic anemia with circulatory compromise, targeting hemoglobin 70-90 g/L (80-100 g/L if unstable coronary disease). 2, 3 Each unit of packed red cells contains only 200 mg elemental iron, insufficient to replenish stores. 2